Avery Polk
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Dermatology top 10%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Lymphoma Diagnosis and Treatment 7
- Cancer Mechanisms and Therapy 2
- Oncology 6
- Viral-associated cancers and disorders 3
- Co-authors
- Ryan A. Wilcox (9 shared papers)Nathanael G. Bailey (7 shared papers)Megan S. Lim (4 shared papers)Ye Lu (4 shared papers)Tianjiao Wang (4 shared papers)Alexandra C. Hristov (4 shared papers)Noah A. Brown (4 shared papers)Stephen M. Ansell (1 shared paper)
- Journals
- Blood (6 papers)Clinical Cancer Research (3 papers)Oncotarget (1 paper)Journal of Clinical Oncology (1 paper)American Journal of Hematology (1 paper)
- Partner nations
- United StatesPeruCanada
In The Last Decade
Avery Polk
13 papers receiving 308 citations
Peers
Comparison fields: 5 of 49
- Pathology and Forensic Medicine 167
- Dermatology 67
- Immunology 160
- Oncology 139
- Genetics 50
Countries citing papers authored by Avery Polk
This map shows the geographic impact of Avery Polk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avery Polk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avery Polk more than expected).
Fields of papers citing papers by Avery Polk
This network shows the impact of papers produced by Avery Polk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avery Polk. The network helps show where Avery Polk may publish in the future.
Co-authors
The 25 scholars most cited alongside Avery Polk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 132 | |
| 2 | 2019 | 48 | |
| 3 | 2016 | 45 | |
| 4 | 2016 | 38 | |
| 5 | 2017 | 21 | |
| 6 | 2017 | 11 | |
| 7 | 2022 | 6 | |
| 8 | 2020 | 3 | |
| 9 | 2019 | 3 | |
| 10 | 2019 | 2 | |
| 11 | 2019 | 2 | |
| 12 | 2014 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2024 | 0 |
About Avery Polk
Avery Polk is a scholar working on Pathology and Forensic Medicine, Oncology, Hematology, Molecular Biology and Immunology, having authored 14 papers that have together received 313 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (4 papers), Immune Cell Function and Interaction (4 papers), Viral-associated cancers and disorders (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (167 citations), Dermatology (67 citations), Immunology (160 citations), Oncology (139 citations) and Genetics (50 citations). Avery Polk has collaborated with scholars based in United States, Peru and Canada. Frequent co-authors include Ryan A. Wilcox, Nathanael G. Bailey, Megan S. Lim, Ye Lu, Tianjiao Wang, Alexandra C. Hristov, Noah A. Brown, Stephen M. Ansell, Thomas E. Witzig and Thomas M. Lanigan. Their work appears in journals such as Blood, Clinical Cancer Research, Oncotarget, Journal of Clinical Oncology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.